Abiopharma

🔍 Idnani Vishal (Executive)

Company: WESTERN ALLIANCE BANCORPORATION (WAL)

Report Date: 2026-03-15

Detailed Transactions and Holdings:

• Acquired 123 shares of Common Stock (Direct)
  Date: 2026-03-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 11,591.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 123 shares of Common Stock at $67.97 per share (Direct)
  Date: 2026-03-15 | Code: D | equity_swap_involved: 0 | shares_owned_after: 11,468.00 | transaction_form_type: 4
• Sold 123 shares of Cash Settled Restricted Stock Units (Derivative)
  Date: 2026-03-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,289.00 | transaction_form_type: 4 | Footnotes: F2, F2, F1, F1

Footnotes:

• F1: These units vest and are payable solely in cash as follows: 1/36th on the 15th day of each month during the 36-month period beginning March 2026 and ending February 2029.
• F2: Each unit is the economic equivalent of one share of Western Alliance Bancorporation common stock.